BioMarin Pharmaceutical
Develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions.
Launch date
Employees
Market cap
€14.6b
Enterprise valuation
€14.5b (Public information from Sep 2024)
Share price
$71.41 BMRN
San Rafael California (HQ)
Authorizing premium user...